What is the honest assessment of KM after 6 months as CEO? He definitely speaks better than JT s who sounded more like a garbage man than a CEO. But performance is still poor with declining scripts and no meaningful progress in other areas (EU, China, combos).
Seems very smiley and all talk.
Yes Karim talks the talk better than JT, but like JT he doesn’t deliver. He’s happy to get minted as CEO where is job is to tell stories about the future in EU while going years delivering nothing. By the time everyone realizes his bullshit, he’s already rich.
Same old story.
Based on actual results delivered in 6 months I’d say he’s just as bad as JT. No impact on company performance whatsoever.
He’s worse than JT if that’s even possible. Todays ER was his report card and the street has given him his grade. COVID is not the reason and he’s been at the helm long enough to right the ship.
If Denner is half the man his Daddy Carl Icahn was KM will be gone with the year.
It must be nice to be Awful at your job and make millions. Guy is a bigger crook than most convicts. Jesus man; earn your paycheck
Simply put, KM’s sole job is to talk with some level of clarity and confidence (something JT could not do) to the BOD and investors about plans that might, but probably won’t, come to fruition so that investors will allow the BOD to keep their jobs (reputations, minor pay, some options) a bit longer while essentially doing nothing. Taking SOME action (new CEO) creates the illusion that the BOD is actually doing something useful when, in fact and based on the results, we know they are not. It’s just a game of kicking the “results” can down the road a bit longer at everyone else’s expense (investors mainly but also eventually most of the employees that take paychecks) so they can save face before the inevitable end.
Eventually, the charade will stop but it will be slow and painful. The BOD will quietly disappear into the night saying “we tried everything but the patents…”, investors will forget and they will do it all over again. The reps will do what they do and some will spin it into another shitty job while others will not be as successful and move on to do something else. All will have succeeded at nothing more than collecting a mediocre paycheck for a while while the execs and BOD milked it for all it was worth. NOBODY will ever be honest about any of it, including most of you.
That’s your career in a nutshell. I hope one or two of you realizes the statistical futility in all of this and leaves this circus to go and do something more meaningful with your lives, instead of wasting them working for KM and others like him.
Good luck.
Tho if the Judge Du decision was the reverse and Vascepa was rocking in the US, none of what you said would be true. It honestly just sounds like a lot of cynical bitterness overflowing out of you and onto your keyboard.
Do you think the European expansion is just a charade and will not eventually contribute to new revenue and growth? It takes a long time to launch pharmaceutical products in Europe. It is nothing like in the US. Companies usually plan for launches like Amarin is doing for many years in advance.
This isn't a hard defense of Amarin or their decisions. We all know there have been some poor ones, like not having even a tentative European launch plan in place and knowing you are involved in litigation that could force you away from the US market. Or not being smart enough in litigation to begin with and losing a battle that should have been won. But your take just sounds like Debbie Downer cynicism and completely discounts the work and time it takes to launch in Europe and in many markets and countries. No CEO could make that happen faster than KM because it is the pace of European governments that dictates this, not just executive effort.
Dear Company Man (or Woman),
IF only this happened and IF ONLY that didn’t happen then “none of this would be true” is simply your way of coping with the situation before you and trying to keep your chin up. Bravo, more power to you. Life and business can be a struggle for sure so if this is what keeps you charging into work everyday then great. We all need an income and a purpose.
The problem is, these things did happen. Judge Du did decide to invalidate the patents. Market share is being lost to the generics. The stock price is literally crumbling daily. Your colleagues have been fired and there is more to come. The BOD is incapable of changing things in a meaningful way in a reasonable amount of time that will improve the situation for most that remain. KM and the BOD will in the end be fine, but will you (the staff)? Unless you’re at the top of this company, you’re not holding a very good hand.
So take your chances with KM if you like, but at least know the game they’re playing and where you stand in that game. Or take matters into your own hands and find something better. Be the master of your own destiny.
Either way, best of luck.
Dear Company Man (or Woman),
IF only this happened and IF ONLY that didn’t happen then “none of this would be true” is simply your way of coping with the situation before you and trying to keep your chin up. Bravo, more power to you. Life and business can be a struggle for sure so if this is what keeps you charging into work everyday then great. We all need an income and a purpose.
The problem is, these things did happen. Judge Du did decide to invalidate the patents. Market share is being lost to the generics. The stock price is literally crumbling daily. Your colleagues have been fired and there is more to come. The BOD is incapable of changing things in a meaningful way in a reasonable amount of time that will improve the situation for most that remain. KM and the BOD will in the end be fine, but will you (the staff)? Unless you’re at the top of this company, you’re not holding a very good hand.
So take your chances with KM if you like, but at least know the game they’re playing and where you stand in that game. Or take matters into your own hands and find something better. Be the master of your own destiny.
Either way, best of luck.
Exactly, also look at the reps they retained. Hardly stellar. Award winning reps were let go. They will eventually cut all from US and focus on Europe, which will also eventually fail
Exactly, also look at the reps they retained. Hardly stellar. Award winning reps were let go. They will eventually cut all from US and focus on Europe, which will also eventually fail
Welcome to pharma jerkoff, this isn't exclusive to Amarin leadership. What a prediction! You must be Nostradamus, stating the obvious like that!
